Clinical Trials Browser

Completed × Hematologic Neoplasms × Busulfan × Clear all

Graft vs Host Disease, Hematologic Neoplasms

NCT02129582 2021-05-07

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00997386 2019-09-09

ALBUM

Phase 2 Completed

16 enrolled 7 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms, Primary Myelofibrosis

NCT00796562 2019-03-14

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Phase 2 Completed

107 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

NCT01572181 2018-04-05

FB4-PEDIA

Phase 2 Completed

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Phase 1 Completed

33 enrolled

LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00361140 2017-03-03

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Phase 4 Completed

72 enrolled 10 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00800839 2016-09-19

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Phase 2 Completed

56 enrolled 10 charts

LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01056614 2016-05-06

Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies

Phase 2 Completed

23 enrolled

MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Myeloproliferative Disorders, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00618969 2016-03-03

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

Phase 2 Completed

2 enrolled

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00809276 2015-02-16

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Phase 1/2 Completed

92 enrolled 5 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00496340 2014-06-05

Pento & tBU

Phase 2 Completed

42 enrolled 15 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00841724 2012-05-16

ITT 08-01

Phase 2 Completed

82 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00208923 2012-04-06

Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies

Phase 2 Completed

55 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00506857 2012-02-28

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Phase 1/2 Completed

82 enrolled 6 charts

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00582894 2011-04-22

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

Phase NA Completed

17 enrolled 9 charts

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT00458250 2008-11-18

Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H

Phase 1 Completed

10 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

ALBUM

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

FB4-PEDIA

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Pento & tBU

ITT 08-01

Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H